VIE/BMYS (VIE/BMYS)

Vienna Stock Exchange: VIE/BMYS · EUR

€54.4

+0.16 (+0.3%)· Recorded snapshot

Market cap	112.3B
Revenue (ttm)	44.1B
Net income (ttm)	8.1B
EPS (ttm)	€4.04
P/E (trailing)	13.5x
P/E (forward)	9.5x
Dividend	€2.19 (4.03%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 44.1B
Net income (ttm): 8.1B
EPS (ttm): €4.04
P/E (trailing): 13.5x
P/E (forward): 9.5x
Market cap: 112.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E9.5

P25 14.3P50 18.7P75 25.4

Trailing P/E13.5

P25 20.4P50 26.7P75 39.7

ROE46.6

P25 4.8P50 10.6P75 20.1

ROIC23.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/BMYS indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-29
Employees	32,500
Employees change	0
Employees growth	0%
Enterprise value	EUR 142.4B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1887
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US1101221083
Last earnings date	2026-10-29
Last refreshed	2026-10-30
Market cap	EUR 112.3B
Next earnings date	2027-02-04
Price	EUR 54.39
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	vie/BMYS
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.04x
Average P/E ratio (3Y)	16.1x
Average P/E ratio (5Y)	18.6x
Earnings yield	7.43%
EV/Earnings	17.5x
EV/EBIT	9.79x
EV/EBITDA	8.33x
EV/FCF	13.91x
EV/Sales	3.18x
FCF / EV yield	7.19%
FCF yield	9.11%
Forward P/E	9.53x
Graham number	29.05126
Graham upside	-46.59%
Lynch fair value	EUR 19.71
Lynch upside	-63.77%
P/(FCF - SBC) ratio	11.53x
P/(OCF - SBC) ratio	10.27x
P/B ratio	5.71x
P/E ratio	13.45x
P/FCF ratio	10.97x
P/OCF ratio	9.82x
P/S ratio	2.55x
Price/EBITDA ratio	6.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	32.35%
EBITDA margin	38.06%
Effective tax rate	18.44%
FCF margin	23.26%
Gross margin	70.5%
Operating margin	32.35%
Pretax margin	22.65%
Profit margin	18.47%
Profit per employee	EUR 250,443
Profitable quarters	10
Profitable years	1
Revenue per employee	EUR 1.4M
ROA	10.72%
ROA (5Y)	6.51%
ROCE	22.67%
ROE	46.6%
ROE (5Y)	13.18%
ROIC	23.45%
ROIC (5Y)	14.63%
SBC / revenue	1.12%
Tax / revenue	4.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	51.93%
EPS growth (Q)	-2.78%
EPS growth (QoQ)	-35.19%
EPS growth 10Y	8.48%
EPS growth 3Y	4.61%
EPS growth years	1
FCF growth	-21.53%
FCF growth 3Y	2.19%
FCF growth 5Y	-0.43%
Gross profit growth	0.4%
Gross profit growth (Q)	0.29%
Gross profit growth 3Y	0.64%
Gross profit growth 5Y	-0.54%
Net income growth	53.06%
Net income growth (Q)	-1.77%
Net income growth (QoQ)	-34.82%
Net income growth 3Y	3.71%
Net income growth years	1
OCF growth	-19.62%
OCF growth 10Y	25.24%
OCF growth 3Y	2.56%
OCF growth 5Y	0.44%
Operating income growth	13.08%
Operating income growth (Q)	14.44%
Operating income growth 3Y	24.09%
Operating income growth 5Y	12.45%
Revenue growth	4.16%
Revenue growth (Q)	6.93%
Revenue growth (QoQ)	0.74%
Revenue growth 10Y	10.48%
Revenue growth 3Y	3.65%
Revenue growth 5Y	1.93%
Revenue growth quarters	6
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.2B
Depreciation and amortization	EUR 2.6B
EBIT	EUR 14.3B
EBITDA	EUR 16.8B
EPS	EUR 4.04
Financing cash flow	EUR -10.5B
Free cash flow	EUR 10.2B
Free cash flow minus SBC	EUR 9.7B
Gross profit	EUR 31.1B
Income taxes	EUR 1.8B
Investing cash flow	EUR -4.4B
Net borrowing	EUR -5.8B
Net cash flow	EUR -3.5B
Net income	EUR 8.1B
Operating cash flow minus SBC	EUR 10.9B
Operating income	EUR 14.3B
Revenue	EUR 44.1B
Stock-based compensation	EUR 494.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 9.62
Debt / EBITDA	2.37
Debt / equity	2.02
Debt / FCF	3.88
Interest coverage	9.79
Net cash (debt)	EUR -29.6B
Net cash / market cap	-26.33%
Net debt / EBITDA	1.76
Net debt / equity	1.5
Net debt / FCF	2.89
Piotroski F-Score	6
Shareholders' equity	EUR 19.7B
Tangible book value	EUR -14.8B
Tangible book value per share	EUR -7.24
Total cash	EUR 9.7B
Total debt	EUR 39.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current ratio	1.53
Inventory turnover	5.09
Quick ratio	1.29
Working capital	EUR 8.9B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.48%
Dividend growth	-1.33%
Dividend growth (3Y)	1.02%
Dividend growth (5Y)	5.82%
Dividend growth years	4
Dividend payment date	2026-11-02
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.19
Dividend yield	4.03%
Ex-dividend date	2026-10-02
Last dividend	EUR 0.56
Payout ratio	54.21%
Shareholder yield	3.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 52.37
1D price change	0.3%
1M price change	-2.21%
1M total return	-1.23%
1W price change	-3.07%
1W total return	-3.07%
1Y price change	47.2%
1Y return CAGR	53.74%
1Y total return	53.7%
20-day SMA	EUR 53.85
200-day SMA	EUR 51.79
3M price change	-3.01%
3M total return	-2.04%
3Y price change	12.38%
3Y return CAGR	8.93%
3Y total return	29.26%
50-day SMA	EUR 55.30
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 60.85
52-week high date	2026-08-03
52-week low	EUR 36.69
52-week low date	2025-10-29
5Y price change	10.91%
5Y return CAGR	6.38%
5Y total return	36.21%
6M price change	8.78%
6M total return	11.09%
All-time high	EUR 80.73
All-time high date	2022-11-09
All-time low	EUR 36.42
All-time low date	2024-07-05
Average true range (ATR)	EUR 1.19
Average volume	9
Change from 52-week high	-10.62%
Change from 52-week low	48.24%
Change from all-time high	-32.63%
Change from all-time low	49.36%
Change from open	-1.68%
Day's gap	2.01%
High price	EUR 55.32
Low price	EUR 54.39
Monthly RSI	56.45
Open price	EUR 55.32
Position in 52-week range	0%
Previous close	EUR 54.23
Price vs 150-day SMA	3.85%
Price vs 20-day SMA	1.01%
Price vs 200-day SMA	5.02%
Price vs 50-day SMA	-1.65%
Relative volume	19.57
RSI	50.03
Sharpe ratio	1.51
Sharpe ratio (3Y)	0.19
Sharpe ratio (5Y)	0.21
Sortino ratio	2.67
Sortino ratio (3Y)	0.49
Sortino ratio (5Y)	0.53
Weekly RSI	54.63
YTD price change	18.01%
YTD total return	23.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2B
Shares change (QoQ)	0.24%
Shares change (YoY)	0.48%
Shares held by insiders	0.05%
Shares held by institutions	83.08%
Short ratio	4.3 days

Deeper analysis on VIE/BMYS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/BMYS report

Is a complete VIE/BMYS research report available?

No complete published report is available for vie/BMYS (VIE/BMYS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/BMYS (VIE/BMYS)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/BMYS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/BMYS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/BMYS

Frequently asked questions